Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rajesh Krishna

Showing results (91-100 of 97) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 97 results.
Clinical Pharmacology and Therapeutics|August 16, 2024
Getting the Dose Right in Drug Development for Rare Diseases: Barriers and EnablersMariam A Ahmed, Rajesh Krishna, Noha Rayad, et al.
Lancet (London, England)|December 11, 2007
Effect of the cholesteryl ester transfer protein inhibitor, anacetrapib, on lipoproteins in patients with dyslipidaemia and on 24-h ambulatory blood pressure in healthy individuals: two double-blind, randomised placebo-controlled phase I studiesRajesh Krishna, Matt S Anderson, Arthur J Bergman, et al.
Journal of Clinical Pharmacology|May 27, 2016
Pharmacokinetics and Pharmacodynamics of Omarigliptin, a Once-Weekly Dipeptidyl Peptidase-4 (DPP-4) Inhibitor, After Single and Multiple Doses in Healthy SubjectsRajesh Krishna, Carol Addy, Daniel Tatosian, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 18, 2009
Metabolism and excretion of anacetrapib, a novel inhibitor of the cholesteryl ester transfer protein, in humansSanjeev Kumar, Eugene Y Tan, Georgy Hartmann, et al.
Omics : a Journal of Integrative Biology|November 10, 2020
Assembly and Annotation of the Nuclear and Organellar Genomes of a Dwarf Coconut (Chowghat Green Dwarf) Possessing Enhanced Disease ResistanceRajesh Krishna Muliyar, Pallem Chowdappa, Santosh Kumar Behera, et al.
British Journal of Clinical Pharmacology|October 22, 2009
Single-dose pharmacokinetics and pharmacodynamics of anacetrapib, a potent cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjectsRajesh Krishna, Amit Garg, Deborah Panebianco, et al.
JMIR Research Protocols|December 19, 2025
Elderly Activity Life-Space Envelopes (EASE): Development and Feasibility of a Comprehensive, Integrated Protocol for Life-Space Mobility Research in Population HealthYee Sien Ng, Fang Zhao, Lynn Yi-Ching Ho, et al.
Pageof 10

Showing results (91-100 of 97) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 97 results.
Clinical Pharmacology and Therapeutics|August 16, 2024
Getting the Dose Right in Drug Development for Rare Diseases: Barriers and EnablersMariam A Ahmed, Rajesh Krishna, Noha Rayad, et al.
Lancet (London, England)|December 11, 2007
Effect of the cholesteryl ester transfer protein inhibitor, anacetrapib, on lipoproteins in patients with dyslipidaemia and on 24-h ambulatory blood pressure in healthy individuals: two double-blind, randomised placebo-controlled phase I studiesRajesh Krishna, Matt S Anderson, Arthur J Bergman, et al.
Journal of Clinical Pharmacology|May 27, 2016
Pharmacokinetics and Pharmacodynamics of Omarigliptin, a Once-Weekly Dipeptidyl Peptidase-4 (DPP-4) Inhibitor, After Single and Multiple Doses in Healthy SubjectsRajesh Krishna, Carol Addy, Daniel Tatosian, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 18, 2009
Metabolism and excretion of anacetrapib, a novel inhibitor of the cholesteryl ester transfer protein, in humansSanjeev Kumar, Eugene Y Tan, Georgy Hartmann, et al.
Omics : a Journal of Integrative Biology|November 10, 2020
Assembly and Annotation of the Nuclear and Organellar Genomes of a Dwarf Coconut (Chowghat Green Dwarf) Possessing Enhanced Disease ResistanceRajesh Krishna Muliyar, Pallem Chowdappa, Santosh Kumar Behera, et al.
British Journal of Clinical Pharmacology|October 22, 2009
Single-dose pharmacokinetics and pharmacodynamics of anacetrapib, a potent cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjectsRajesh Krishna, Amit Garg, Deborah Panebianco, et al.
JMIR Research Protocols|December 19, 2025
Elderly Activity Life-Space Envelopes (EASE): Development and Feasibility of a Comprehensive, Integrated Protocol for Life-Space Mobility Research in Population HealthYee Sien Ng, Fang Zhao, Lynn Yi-Ching Ho, et al.
Pageof 10